BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 4
• 5
• 7
• 8
• 9
• 10
• 11
• 12
• 14
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30

• Press Releases

  Ezurio Appoints Isaac Lund as Chief Financial Officer to Strengthen Financial Leadership and Drive Continued Growth

  June 18, 2026

   · 

  2 min read
• Press Releases

  Lancet Neurology study confirms staged bilateral focused ultrasound delivers substantial, durable relief for Parkinson’s disease

  June 18, 2026

   · 

  5 min read
• Press Releases

  Daré Bioscience to Showcase Leadership in Women’s Health Innovation at BIO International Convention 2026

  June 18, 2026

   · 

  3 min read
• Press Releases

  New Phase 2a Clinical Data Analysis of Stem Cell Therapy Laromestrocel in Mild Alzheimer’s Disease Accepted for Poster Presentation at the 2026 Alzheimer’s Association International Conference (AAIC)

  June 18, 2026

   · 

  6 min read
• Press Releases

  SK pharmteco Announces Strategic Collaboration with Orphan Therapeutics Accelerator for the Development and Manufacturing of Rare Disease Therapies

  June 18, 2026

   · 

  3 min read
• Press Releases

  AIM ImmunoTech Achieves Clinical Milestone as Final Subject Receives First Dose in Phase 2 DURIPANC Study in Metastatic Pancreatic Cancer

  June 18, 2026

   · 

  7 min read
• Press Releases

  Cadrenal Therapeutics to File for FDA Rare Pediatric Disease Designation for Tecarfarin in Kawasaki Disease

  June 18, 2026

   · 

  8 min read
• 

  Series A

  New biotech cAMPfield emerges with $180M to reshape IBD treatment

  Backed by institutional investors and seasoned industry leaders, cAMPfield Therapeutics is advancing a clinical program aimed at reshaping the landscape for inflammatory bowel disease.

  June 18, 2026

   · 

  2 min read

   · 

  Gabrielle Masson
• Press Releases

  Phio Pharmaceuticals Announces Participation in the Life Sciences Investor Forum on June 24-25, 2026

  The Company invites individual and institutional investors, as well as advisors and analysts with an interest in Phio Pharmaceuticals, to attend the live, interactive presentation and one-on-one meetings

  June 18, 2026

   · 

  5 min read
• Press Releases

  Kiora Pharmaceuticals Reports its Ion Channel Modulator, KIO-300, Suppressed Seizure Activity in Preclinical Epilepsy Model

  Data Presented at Epilepsy Foundation Pipeline Conference Demonstrated Significant Reduction in Epileptiform Activity: KIO-300 is the active pharmaceutical ingredient of KIO-301, Kiora’s ongoing Phase 2 clinical program in vision restoration in patients with gene mutation-agnostic Retinitis Pigmentosa

  June 18, 2026

   · 

  4 min read